Table 1:
Baseline Characteristics of Patients Initiated on a Loop Diuretic within 360 days of Dihydropyridine Calcium Channel Blocker Initiation
| Characteristics | Included Patients (n=90) n(%) |
|---|---|
|
| |
| Age | |
| <65 | 54 (60.0) |
| ≥65 | 36 (40.0) |
|
| |
| Sex | |
| Men | 30 (33.3) |
| Women | 60 (66.7) |
|
| |
| Race | |
| White | 52 (57.8) |
| Black | 33 (36.7) |
| Other | 5 (5) |
|
| |
| DH CCB | |
| Amlodipine | 87 (96.7) |
| Nifedipine | 3 (3.3) |
|
| |
| DH CCB Dose | |
| Low | 9 (10.0) |
| Standard | 54 (60.0) |
| High | 27 (30.0) |
|
| |
| Other Antihypertensive Medication Classes | |
| 0–1 | 43 (47.8) |
| 2–3 | 39 (43.3) |
| ≥4 | 8 (8.9) |
Abbreviations: DH CCB, dihydropyridine calcium channel blockers